Pamela N Munster Selected Research

Pamela N Munster Research Topics

Disease

52	Neoplasms (Cancer) 03/2024 - 02/2002
32	Breast Neoplasms (Breast Cancer) 10/2023 - 02/2002
7	Melanoma (Melanoma, Malignant) 01/2019 - 07/2006
4	Fatigue 01/2022 - 10/2007
4	Amenorrhea 01/2016 - 11/2002
3	Nausea 03/2015 - 02/2007
2	Disease Progression 01/2022 - 10/2015
2	Neutropenia 01/2022 - 03/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 10/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 11/2018 - 12/2015
2	Triple Negative Breast Neoplasms 12/2017 - 09/2017
2	Neoplasm Metastasis (Metastasis) 01/2017 - 12/2008
2	Exanthema (Rash) 12/2015 - 02/2007
2	Noninfiltrating Intraductal Carcinoma (DCIS) 08/2015 - 10/2007
2	Thrombocytopenia (Thrombopenia) 03/2015 - 02/2007
2	Diarrhea 04/2009 - 02/2007
1	Hepatocellular Carcinoma (Hepatoma) 03/2024
1	Cholangiocarcinoma 03/2024
1	Inflammation (Inflammations) 03/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2024
1	Neuroendocrine Carcinoma 01/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Hyperglycemia 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Thrombocytopenia 3 01/2022
1	Glioma (Gliomas) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2021

Drug/Important Bio-Agent (IBA)

11	Estrogen ReceptorsIBA 01/2020 - 03/2006
9	Histone Deacetylases (Histone Deacetylase)IBA 01/2020 - 04/2009
9	Histone Deacetylase InhibitorsIBA 01/2019 - 04/2009
6	Tamoxifen FDA LinkGeneric 10/2023 - 11/2002
5	Trastuzumab (Herceptin)FDA Link 11/2019 - 04/2009
4	Estrogens (Estrogen)FDA Link 10/2023 - 08/2009
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 06/2009
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
4	Hormones (Hormone)IBA 01/2021 - 03/2006
4	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 09/2017
4	ErbB Receptors (EGF Receptor)IBA 11/2019 - 04/2009
3	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2016
3	Fulvestrant (Faslodex)FDA Link 10/2023 - 09/2017
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2015
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022 - 01/2017
3	PlatinumIBA 01/2022 - 09/2017
3	Lactic Acid (Lactate)FDA LinkGeneric 11/2021 - 10/2018
3	AnthracyclinesIBA 11/2019 - 04/2009
3	Monoclonal AntibodiesIBA 01/2017 - 03/2014
3	Valproic Acid (Depakote)FDA LinkGeneric 11/2011 - 12/2005
3	Tyrosine Kinase InhibitorsIBA 04/2009 - 02/2007
2	Aromatase InhibitorsIBA 10/2023 - 06/2013
2	Phosphotransferases (Kinase)IBA 01/2023 - 10/2015
2	pembrolizumabIBA 01/2023 - 01/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 06/2009
2	Taxoids (Taxanes)IBA 01/2022 - 04/2009
2	130-nm albumin-bound paclitaxelIBA 01/2022 - 01/2018
2	GlucocorticoidsIBA 01/2022 - 01/2021
2	sotorasibIBA 01/2022 - 01/2020
2	relacorilantIBA 01/2022 - 01/2021
2	Pyruvic Acid (Pyruvate)IBA 11/2021 - 11/2018
2	veliparibIBA 01/2021 - 09/2017
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 09/2017
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 06/2009
2	Estrogen Receptor Modulators (Antiestrogen)IBA 09/2017 - 08/2011
2	abexinostatIBA 04/2017 - 01/2013
2	MK 2206IBA 02/2016 - 12/2015
2	neratinibIBA 06/2014 - 04/2009
2	Protein Isoforms (Isoforms)IBA 06/2013 - 12/2005
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2012 - 11/2002
2	cositecanIBA 11/2011 - 04/2009
2	Topoisomerase I InhibitorsIBA 11/2011 - 04/2009
2	Vorinostat FDA Link 02/2011 - 11/2009
2	DNA (Deoxyribonucleic Acid)IBA 04/2009 - 12/2008
2	2- methoxy- N- (3- (4- ((3- methyl- 4- ((6- methyl- 3- pyridinyl)oxy)phenyl)amino)- 6- quinazolinyl)- 2- propenyl)acetamideIBA 06/2008 - 02/2007
2	trioctyl phosphine oxide (TOPO)IBA 08/2006 - 05/2004
2	Selective Estrogen Receptor Modulators (SERM)IBA 03/2006 - 03/2003
2	Topoisomerase II InhibitorsIBA 12/2005 - 12/2005
2	Histones (Histone)IBA 12/2005 - 05/2005
1	NivolumabIBA 03/2024
1	LigandsIBA 03/2024
1	Transcription Factors (Transcription Factor)IBA 03/2024
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2024
1	cyclopropapyrroloindoleIBA 01/2023
1	ZinostatinIBA 01/2023
1	8- (6- methoxypyridin- 3- yl)- 3- methyl- 1- (4- piperazin- 1- yl- 3- trifluoromethylphenyl)- 1,3- dihydroimidazo(4,5- c)quinolin- 2- oneIBA 01/2023
1	Lomustine (CCNU)FDA Link 01/2022
1	taxaneIBA 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022
1	AlpelisibIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	pentetreotide (OctreoScan)FDA Link 01/2021

Therapy/Procedure

26	Therapeutics 03/2024 - 11/2002
16	Drug Therapy (Chemotherapy) 01/2023 - 11/2002
4	Aftercare (After-Treatment) 01/2021 - 11/2002
4	Immunotherapy 01/2020 - 12/2008
3	Adjuvant Chemotherapy 02/2012 - 11/2002
3	Radiotherapy 04/2009 - 10/2007
2	Induction Chemotherapy 01/2021 - 01/2019
1	Immunomodulation 01/2022